LENZ Therapeutics

company

About

LENZ Therapeutics is a late-stage clinical company developing innovative ophthalmic pharmaceutical products.

  • 1 - 10

Details

Last Funding Type
Series A
Last Funding Money Raised
$47M
Industries
Medical,Pharmaceutical,Therapeutics
Founded date
Jan 1, 2013
Number Of Employee
1 - 10
Operating Status
Active

LENZ Therapeutics is a late-stage clinical company developing innovative ophthalmic pharmaceutical products that improve vision.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$47M
LENZ Therapeutics has raised a total of $47M in funding over 2 rounds. Their latest funding was raised on Jun 17, 2021 from a Series A round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Jun 17, 2021 Series A $47M 1 Versant Ventures Detail

Investors

Number of Lead Investors
Number of Investors
1
1
LENZ Therapeutics is funded by 1 investors. Versant Ventures are the most recent investors.
Investor Name Lead Investor Funding Round
Versant Ventures Yes Series A